APA (7th ed.) Citation

Y, L., SY, Y., WH, Z., YT, L., JW, F., JY, D., . . . B, Y. (2026). Targeting JOSD2 degrades β-catenin to suppress colorectal cancer metastasis by disrupting RAS/ERK/β-catenin axis. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01886-7

Chicago Style (17th ed.) Citation

Y, Liu, et al. "Targeting JOSD2 Degrades β-catenin to Suppress Colorectal Cancer Metastasis by Disrupting RAS/ERK/β-catenin Axis." Acta Pharmacologica Sinica 2026. https://doi.org/10.1038/s41401-026-01886-7.

MLA (9th ed.) Citation

Y, Liu, et al. "Targeting JOSD2 Degrades β-catenin to Suppress Colorectal Cancer Metastasis by Disrupting RAS/ERK/β-catenin Axis." Acta Pharmacologica Sinica, 2026, https://doi.org/10.1038/s41401-026-01886-7.